Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 06, 2022

SELL
$193.77 - $244.14 $193 - $244
-1 Reduced 0.03%
3,645 $768,000
Q3 2021

Nov 12, 2021

BUY
$282.99 - $369.05 $282 - $369
1 Added 0.03%
3,646 $1.03 Million
Q2 2021

Aug 09, 2021

SELL
$259.0 - $414.71 $2.85 Million - $4.56 Million
-10,993 Reduced 75.1%
3,645 $1.26 Million
Q1 2021

May 10, 2021

BUY
$242.95 - $284.63 $1.11 Million - $1.3 Million
4,551 Added 45.12%
14,638 $4.1 Million
Q4 2020

Feb 10, 2021

SELL
$236.26 - $355.63 $3.04 Million - $4.58 Million
-12,874 Reduced 56.07%
10,087 $2.47 Million
Q3 2020

Nov 06, 2020

SELL
$264.77 - $305.71 $3,971 - $4,585
-15 Reduced 0.07%
22,961 $6.51 Million
Q2 2020

Aug 10, 2020

SELL
$258.66 - $342.55 $58,715 - $77,758
-227 Reduced 0.98%
22,976 $6.15 Million
Q1 2020

May 12, 2020

BUY
$268.85 - $341.04 $129,585 - $164,381
482 Added 2.12%
23,203 $7.34 Million
Q4 2019

Feb 06, 2020

BUY
$220.06 - $304.07 $683,506 - $944,441
3,106 Added 15.83%
22,721 $6.74 Million
Q3 2019

Nov 08, 2019

SELL
$217.44 - $243.88 $89,150 - $99,990
-410 Reduced 2.05%
19,615 $4.57 Million
Q2 2019

Aug 12, 2019

SELL
$219.29 - $241.72 $228,061 - $251,388
-1,040 Reduced 4.94%
20,025 $4.68 Million
Q1 2019

May 10, 2019

BUY
$216.71 - $338.96 $1.64 Million - $2.57 Million
7,588 Added 56.3%
21,065 $4.98 Million
Q4 2018

Feb 08, 2019

SELL
$278.5 - $352.75 $3.43 Million - $4.34 Million
-12,299 Reduced 47.71%
13,477 $4.06 Million
Q3 2018

Nov 13, 2018

SELL
$293.51 - $383.83 $2.56 Million - $3.35 Million
-8,729 Reduced 25.3%
25,776 $9.11 Million
Q2 2018

Aug 09, 2018

SELL
$257.52 - $306.91 $841,060 - $1 Million
-3,266 Reduced 8.65%
34,505 $10 Million
Q1 2018

May 15, 2018

SELL
$260.13 - $367.91 $596,738 - $843,985
-2,294 Reduced 5.73%
37,771 $10.3 Million
Q4 2017

Feb 14, 2018

BUY
$307.64 - $344.58 $1.92 Million - $2.16 Million
6,256 Added 18.5%
40,065 $12.8 Million
Q3 2017

Nov 14, 2017

SELL
$281.15 - $329.69 $11.8 Million - $13.8 Million
-41,973 Reduced 55.39%
33,809 $10.6 Million
Q2 2017

Aug 07, 2017

BUY
N/A
75,782
75,782 $20.6 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Gam Holding Ag Portfolio

Follow Gam Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Gam Holding Ag with notifications on news.